Healthtech Startups

Bioretec develops fully biodegradable orthopedic implants for fracture healing and orthopedic surgery, including the RemeOs product line based on magnesium alloy and the Activa line of bioabsorbable implants. The company serves orthopedic surgeons and patients globally across approximately 40 countries.

1 investor

Bioscibex develops SW1NGO, a single-use system that automates the seed train in biologics manufacturing by scaling directly from 30 mL up to 30 L in one step, eliminating manual cell passaging and reducing contamination risks. It targets biopharma companies and CDMOs involved in upstream process development and manufacturing.

1 investor

Biosens8 develops wearable health monitoring devices that track physiological markers including cortisol and women's health metrics. The company serves health-conscious consumers interested in personal biometric monitoring.

1 investor

Biospectal develops OptiBP, a smartphone app that measures and tracks blood pressure using a fingertip on the phone's camera, allowing users to record BP history and share it with doctors. The app is CE-MDR EU Class IIa certified and targets people managing hypertension and heart health.

1 investor

BioSpeedia is a biotechnology company that develops and produces rapid lateral-flow diagnostic tests for infectious diseases, including tests for bacterial meningitis and SARS-CoV-2. A spin-off from the Institut Pasteur, it distributes its diagnostic products worldwide through affiliated entities.

1 investor

Biospring is an investment firm that partners with technology-enabled, EBITDA-positive pharma services businesses focused on manufacturing and clinical trial services. Its portfolio companies produce and support the supply chain for complex medicines such as biologics, cell therapies, and peptides, and modernize clinical trial site operations, patient recruitment, and related technology for the life sciences industry.

1 investor

Biosurfit develops point-of-care diagnostic instruments and tests for blood analysis, including devices for measuring C-reactive protein, blood counts, and HbA1c levels. The company serves hospitals, clinics, and mobile health units across Europe, and has expanded into contract manufacturing services for diagnostic and medical device companies.

1 investor

Biotheranostics develops proprietary genomic assays used to support personalized disease management in oncology. The company was acquired by Hologic in February 2021.

1 investor

BioticsAI develops AI-powered computer vision solutions for fetal anatomy screening and maternal ultrasound diagnostics. The company serves healthcare providers and maternal-fetal medicine specialists seeking to standardize and improve the accuracy of prenatal ultrasound assessments.

1 investor

BioTissue develops regenerative medicine products derived from human birth tissue to treat wounds and chronic pain. The company's offerings have anti-inflammation and anti-scarring properties and are used by surgeons and healthcare professionals to help patients heal faster.

1 investor

1 investor

1 investor

Biotree develops metabolomics and proteomics analysis platforms and services for research institutions and pharmaceutical companies, offering laboratory testing solutions, medical devices, and cloud-based lab information systems.

1 investor

Biotronics3D provides 3Dnet, a cloud-native medical imaging platform that integrates PACS, RIS, patient portals, and advanced diagnostic visualization tools for healthcare organizations. The solution supports multi-site deployments with AI-driven workflows and enables secure collaboration among healthcare providers and patients.

1 investor

BioVana structures clinical data and biospecimen collections across African health institutions to meet international standards for biomedical research and precision medicine. The company enables biotech, pharma, and academic organizations to access diverse, well-characterized cohorts from African research institutions.

1 investor

The company develops diagnostics and diagnostic solutions for laboratory technicians, physicians, and patients, prioritizing fast and reliable testing capabilities.

1 investor

BioVentrix is a medical device company that develops less invasive therapies to treat heart failure by reconstructing the dilated left ventricle using myocardial micro-anchor implants. The company serves cardiothoracic surgeons and patients with ischemic heart failure.

1 investor

BIOW develops solutions targeting the health effects of air pollution exposure, specifically investigating how bioavailable anions may support mitochondrial function and neural resilience in the context of neurodegenerative diseases and aging. The company conducts clinical research on biomarker changes and microbiome effects through advanced proteomics and metabolomics analysis.

1 investor

BioWave develops patented high-frequency neurostimulation devices that deliver therapeutic stimulation deep into the body to block pain signals at the nerve source, aimed at chronic pain patients and athletes. Its products are used in settings such as Veterans Affairs, orthopedic and pain health systems, and by professional sports trainers.

1 investor

Bioxis develops proprietary biomaterials based on chitosan and hyaluronic acid for aesthetic dermatology applications. The company creates tissue induction products designed to regenerate tissue and collagen with long-lasting effects.

1 investor

Birchgrove develops housing and residential communities designed for older adults seeking independent living with support services. The company focuses on creating neighborhoods that combine accessibility, design, and community support.

1 investor

Birdhouse operates a micro-center for early childhood care and education serving children ages 2-5, with a maximum capacity of 12 children designed to enable individualized, play-based learning. The center offers flexible hours, in-house meals, and curriculum informed by Montessori, Reggio-Emilia, and Conscious Discipline approaches.

1 investor

Birth Model uses machine learning and patient data to predict delivery times and optimize labor and delivery operations in hospitals. The platform helps manage staffing, reduce patient wait times, and improve operational efficiency for obstetric care providers.

1 investor

Bisc Therapeutics develops Bax inhibitor therapies designed to prevent retinal cell death and preserve vision in patients with retinal degenerative diseases such as age-related macular degeneration, glaucoma, and inherited retinal disorders. The company operates in the biotech/ophthalmology therapeutics space.

1 investor